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Nitric oxide is a chemical messenger which functions as a
neurotransmitter or as a cytotoxic agent Nitric oxide
synthase (NOS) has been isolated from various mammalian
reproductive tissues. The presence or absence of NOS in
spermatozoa has not yet been reported. We therefore tested
human and marine spermatozoa for NOS activity by
measuring the conversion of arginine to citmlline. No
activity was found either in human or in murine spermato-
zoa. Human native semen and human seminal plasma
exerted an inhibition on brain NOS activity, as assayed on
rat brain cytosolic fractions. This inhibitory effect was
dependent on the amount of protein present in the human
seminal plasma. No inhibitory effect was observed when
homogenates of washed spermatozoa were tested. The
human seminal plasma did not affect the Michaelis constant
(Km) of NOS for L-arginine (endogenous NOS substrate)
whereas the maYimnl velocity (Vmax) was reduced, sug-
gesting that it contains a non-competitive inhibitor of brain
NOS. This inhibitory component was virtually insensitive
to heat; a 10 min treatment to 95°C only slightly reduced
its ability to inhibit brain NOS. The physiological relevance
of our observations remains to be elucidated. Human
seminal plasma may exert an inhibition of nitric oxide
synthesis on cells other than spermatozoa or on cells from
the male or female genital tract, modulating directly or
indirectly (via modulation of reactive oxygen species forma-
tion) the functional state of the spermatozoa.
Key words: male infertility/nitric oxide/reactive oxygen species/
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Introduction
Defective sperm function has been identified as one of the
causes of human infertility. Little is known yet about the
biochemical nature of sperm dysfunction. Spermatozoa have
to be maintained in a latent state during the periods of
epididymal storage and migration to the site of fertilization.
Thereafter, spermatozoa undergo a cluster of physiological and
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biochemical alterations as a consequence of exposure to
female genital tract secretions or to an appropriate in-vitro
environment. This process is known as capacitation. Capacit-
ation is essential for fertilization and is characterized by
hyperactivated motility; it prepares die spermatozoa for the
acrosome reaction (Yanagimachi, 1994).
Nitric oxide (NO) was first identified as an endothelium-
derived relaxing factor. Its role in cardiovascular regulation,
platelet aggregation, and the tumoricidal and bactericidal
activities of macrophages is now widely accepted. The auto-
nomous nervous system uses NO as a non-adrenergic, non-
cholinergic neurotransmitter in contractile and secretory tissues
to decrease muscle tone (for a review, see Schmidt and
Walter, 1994).
NO is synthesized by a family of enzymes, the nitric oxide
synthases (NOS). Constitutive, Ca2+-dependent enzymes are
found in endothelial cells and neurons, and an inducible, Ca2+-
independent form is seen in macrophages, neutrophils and also
in endothelium (reviewed by Nathan and Xie, 1994).
There is evidence to suggest that NO may be involved in
both normal (Hellstrom et al, 1994) and abnormal (Rosselli
et al, 1995; Weinberg el al, 1995) sperm functions.
In addition, it is known that NO reacts with the superoxide
anion O2~ and hence can modulate its effects. Superoxide
anion or hydrogen peroxide (H2O2) can contribute either to
peroxidation and toxic effects on spermatozoa (Aitken et al,
1989; Iwasaki and Gagnon; 1992; de Lamirande and Gagnon,
1992) or to their capacitation and hyperactivation (Aitken
etal, 1989,1995;Bize«f a/., 1991; de Lamirande and Gagnon,
1993, 1995).
The aims of our study were to test human and mouse
spermatozoa for the intracellular presence of NOS activity;
this study led to the detection of an inhibitory effect of brain
NOS in human seminal plasma (HSP). We used rat brain
homogenates as a source of high NOS-containing tissue (Salter
etal, 1991).
Materials and methods
Mouse spermatozoa
Male BRL mice (4-5 months) were killed by decapitation, and the
spermatozoa were collected from two vas deferens in 0.4 ml of a
Krebs-Ringer buffer (Sigma K4002) containing NaCl (120 mM),
MgCl2 (0.49 mM), KC1 (4.56 mM), Na2HPO4 (0.7 mM), NaH2PO4
(1.5 mM), glucose (10 mM), supplemented with NaHCO3, (25 mM),
CaCl2 (1.71 mM), sodium pyruvate (1 mM), sodium lactate (25 mM)
and 2% bovine serum albumin (BSA) (buffer A). They were cultured
in an atmosphere of 5% CO2 in air, pH 7.4. Only samples showing
>70% motility were used. Spermatozoa were collected by
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Figure 1. Nitric oxide synthase (NOS) activity in human semen,
human seminal plasma and spermatozoa. Samples containing 30 |ig
of protein were assayed for NOS activity, as described in the text.
Data represent the mean ± SEM of the number of determinations
indicated in the figure. SPZ = sperm homogenate. Similar negative
results were obtained in five samples containing 300 |ig of sperm
cell protein.
centrifugation (14 000 g, 5 min, 4°C) and stored at -80°C until use.
The pellet was resuspended in 150 \il of 50 mM HEPES, pH 7.4,
containing 1 mM EDTA (buffer B) and homogenized by sonication
on ice. Ion-exchange resin (50 mg, AG50WX-8, sodium form) was
then added to remove endogenous arginine (Bugnon et al., 1994),
and after 5 min, by which time the resin had settled to the bottom of
the tube, the supernatant was carefully removed and transferred to
another tube. NOS activity was measured in 10 |il samples containing
30 (ig of protein (see below).
Human spermatozoa and HSP
Human semen samples were obtained from donors. Ejaculates were
collected by masturbation after 4 days of abstinence. Standard
routine sperm parameters (volume, pH, sperm concentration, motility,
morphology, viability, white blood cells, bacteria) were determined
within 2 h of sample collection, and the semen was stored at -80°C.
Samples (500-1000 uJ) were centrifuged (14 000 g, 5 min, 4°C) to
separate sperm cells (unwashed spermatozoa) from HSP. Spermatozoa
were sometimes resuspended in 0.9% NaCl (1 ml) and centrifuged
again before homogenization (washed spermatozoa). The pellet was
resuspended in buffer B and homogenized by sonication on ice. Then
50 mg of ion-exchange resin (AG50WX-8, sodium form) was added
to remove endogenous arginine. HSP was also treated with resin, as
described above. In some experiments that excluded freezing the
semen specimens, the spermatozoa were separated from HSP by
centrifugation at 300 g (10 min) after adding two volumes of standard
culture medium (Whittingham's T6; Quinn et al., 1982). The pellets
containing spermatozoa and other cells present in the ejaculate were
resuspended in the same medium (300 |il). The motile spermatozoa
were obtained by mini-Percoll gradient centrifugation (Ord et al.,
1990). They were further washed and centrifuged again, as described
above, before biochemical assay. The supernatant containing HSP
was recovered for analysis.
Brain homogenate preparation
Animals were decapitated, and their brains were dissected, homo-
genized at 4°C in buffer B and treated with ion-exchange resin.
Cytosolic fractions were prepared by centrifugation (39 000 g, 30 min,
4°C). Samples containing 30 ng of protein were routinely used.
NOS assay
NOS activity was assayed in triplicate by measuring the conversion
of [3H]arginine to [3H]citrulline according to our modification of the
Figure 2. Inhibitory effect of human semen on brain nitric oxide
synthase (NOS). Rat brain NOS activity was measured in the
presence of 20 |ig of human semen, human seminal plasma, and
intact or washed sperm homogenate (SPZ), as described in the text
Data represent the mean ± SEM of the number of 9-12
determinations obtained in three or four different experiments.
*• = significantly different from control (P < 0.01). In a separate
set of experiments using six more samples, we separated HSP from
sperm cells without freezing and assayed for inhibitory effects: a
95.3 ± 0.8% inhibition was measured.
Human seminal plasma {pg protein)
Figure 3. Dose-dependent inhibition of rat brain nitric oxide
synthase (NOS) activity. Rat brain NOS (30 u.g) was measured in
the presence of various amounts of human seminal plasma, as
described in the text Data represent the mean ± SEM of 9-12
determinations obtained in four different experiments. Doses > 2 |j.g
inhibited brain NOS activity {P < 0.01).
Bredt and Snyder (1990) method (Schaad et al., 1994). Briefly, a
10 |xl homogenate was added to 15 pJ of a reaction mixture containing
CaCl2 (final concentration 1.25 mM), EDTA (1 mM), flavin-adenine
dinucleotide (FAD; 10 uM), flavin mononucleotide (FMN; 10
5,6,7,8-tetrahydrobiopterin (THB; 100 uM), calmodulin (10
arginine (25 |iM, unless otherwise indicated), dithiothreitol (1 mM)
and NADPH (1 mM).
Protein measurement
Protein concentration was determined by a dye-binding method
(Bradford, 1976), using BSA as a standard.
Statistics
Data are presented as the mean of the indicated number of determina-
tions. Vertical error bars represent the SEM of the number of
determinations, as detailed in the legends. Statistical analysis was
performed with unpaired Student's f-test or as otherwise indicated,
using a graphic software (Fig.P.; Biosoft, Cambridge, UK).
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Figure 4. Effect of human seminal plasma (HSP) on rat brain nitric oxide synthase (NOS) A"™ and V ^ . Rat brain NOS activity was
measured, as described in the text, in the presence of various concentrations of L-arginine, and in the presence (closed circles) or absence
(open circles) of 3.5 |ig of HSP protein. Results are representative of three independent experiments.
Material Suppliers
Reagents were purchased from following sources: NaHCO3, sodium
pyruvate, sodium lactate, glucose, THB, CaCl2 and HEPES from Fluka
(Buchs, Switzerland); Krebs-Ringer buffer, dithiothreitol, arginine,
calmodulin, FAD, FMN and EDTA from Sigma (Buchs, Switzerland);
AG50WX-8, sodium form resin from BioRad (Glattbrugg,
Switzerland); NADPH from Boehringer Mannheim (Rotkreuz,
Switzerland); BSA (Fraction V) from Hoechst (Buchs, Switzerland).
Results
When NOS activity was measured in human spermatozoa, no
activity was found in 37 samples out of 40. A faint activity
was nevertheless observed in three donors whose samples
were not associated with any abnormality as estimated by the
parameters used in our andrology laboratory (sperm count,
motility, morphology, vitality, presence of bacteria or white
blood cells). In homogenates of spermatozoa containing a
higher (300 \lg) protein concentration, NOS activity was also
undetectable. HSP or total semen homogenates did not display
any NOS activity (Figure 1). Negative results were also
obtained in six additional semen specimens that were separated
from HSP without any freezing procedure, using a mini-Percoll
gradient Similar negative results were obtained with murine
spermatozoa.
We then investigated whether human spermatozoa could
inhibit brain NOS activity. We routinely used the cytosolic
fraction of rat brain as a NOS-containing tissue to estimate
the possible inhibitory activity of various samples. As shown
in Figure 2, rat brain NOS was >80% inhibited when 20 ng
of proteins contained in whole semen homogenate were added.
The origin of the factor responsible for the sperm inhibitory
activity was then investigated by separating sperm cells from
HSP. HSP provoked a strong inhibition when tested alone.
Homogenates prepared from unwashed sperm cells exerted
some inhibition on brain NOS activity; however, when they
were washed before homogenization, they lost their inhibitory
effect The inhibitory activity of HSP on brain NOS activity
was dependent on the concentration of protein, as shown in
Figure 3. The half-maximal effect on rat brain NOS (30 ng)
was observed using 2 Hg of proteins from HSP. Addition of
20 ng of protein from HSP almost completely abolished brain
NOS activity. To characterize such an inhibition further,
the kinetics of brain NOS were examined using various
concentrations of the NOS substrate, L-arginine. In three
independent experiments, the addition of HSP (at a submaximal
inhibitory concentration) to the reaction mixture did not affect
the Km for brain NOS whereas it reduced the Vmax, as shown
in Figure 4. These results suggest that the component present
in HSP is capable of inhibiting brain NOS activity in a non-
competitive manner. We then investigated if 20 (Xg of BSA or
20 }ig of proteins from human blood serum could inhibit brain
NOS activity, and found that these agents did not share the
inhibitory effect of HSP (data not shown).
A brief heat treatment of HSP (10 min boiling) only slightly
affects its inhibitory activity, indicating that the active agent
is most probably not a protein, or alternatively is a heat-
resistant protein or a peptide.
Discussion
Our results show that brain NOS activity (measured by the
conversion of arginine to citrulline) is not detectable in human
or in murine spermatozoa. These data agree with those recently
reported by Zini et al. (1995). Interestingly, HSP is shown to
contain an endogenous inhibitor of brain NOS. This inhibitor
strongly affects brain NOS activity, depending on the concen-
tration of protein present in HSP. The equivalent of 20 ng of
protein from HSP inhibits the NOS activity present in 30 |ig
brain protein.
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The physiological relevance of such results is presently
unclear, but is certainly related to a reduction in NO synthesis.
The importance of NO on sperm function has been poorly
investigated. Since spermatozoa do not possess detectable
NOS activity, such an inhibitor may only affect NOS from
associated cells or leukocytes, preventing their production of
NO, or NOS from cells of reproductive tissues (Jovanovic
et al., 1994; Telfer et al., 1995). Moreover the main target of
NO is known to be the soluble form of guanylate cyclase.
However, no convincing evidence for its presence in mamma-
lian sperm cells has been reported as yet. NO elaborated in
the female genital tract (Jovanovic et al., 1994; Telfer et al,
1995) in vivo has been reported to influence sperm function
and fertility adversely (Rosselli et al, 1995; Weinberg et al,
1995) through an inhibition of sperm respiratory function.
In addition, NO can react with reactive oxygen species
(ROS) to modulate their functions. The generation of ROS by
human spermatozoa has been implicated either in the control
of normal sperm function (Aitken et al, 1995) or in the
aetiology of male infertility (Jones et al, 1979; Aitken et al,
1989; Alvarez and Storey; 1989; De Lamirande and Gagnon,
1992). The generation of ROS plays a key role in the control
of sperm biological responses through the redox regulation of
tyrosine phosphorylation (Aitken et al, 1995) that is an
essential component of the cascade of biochemical changes
that lead to acrosomal exocytosis and fusion with an oocyte.
In contrast to their positive effects, the generation of ROS
leads to a peroxidation-induced loss of plasma membrane
function leading to sperm immobilization (Aitken et al, 1989;
de Lamirande and Gagnon, 1992; Iwasaki and Gagnon, 1992).
NO and superoxide are not strong oxidants, but they can
react together to form peroxynitrite (Koppenol et al, 1992).
Peroxynitrite can further release the hydroxyl radical, which
is a strong oxidant that can damage cells (Pryor and Squadrito,
1995; Squadrito and Pryor, 1995). By inhibiting NO generation,
maybe the amount of hydroxyl radical can be decreased,
preventing the subsequent lipid peroxidation involved in cellu-
lar damage.
Concerning HSP, it is known that it contains both positive
and negative modulators of fertility preventing the development
of acrosomal responsiveness or enhancing the acrosome reac-
tion (Cross, 1993). Caltrin (also known as seminal plasmin)
and several other seminal proteins have been identified as
decapacitating factors (reviewed in Cross, 1993); they include
the acrosome-stabilizing factor (Eng and Oliphant, 1978) and
spermine (Rubinstein and Breitbart, 1991). An agent inhibiting
NO synthesis, such as the one that we report here, could
therefore represent an indirect modulator of sperm activation
(capacitation and acrosome reaction).
Most probably, the inhibitory components) of HSP is not
a protein, since pre-heating only weakly attenuates its effect.
Several endogenous inhibitors of NOS have been described.
These are mainly amino acid derivatives, such as substituted
L-arginine: Af-monomethylarginine, A^^-dimethylarginine,
M^^-dimethylarginine or a-guanidinoglutaric acid
(Kakimoto and Akazawa, 1970; Yokoi et al, 1994). It has
been demonstrated that spermine and .spermidine can also
reduce brain NOS activity (Hu et aL, 1994). We do not think
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that the inhibitory component present in HSP is either an
arginine analogue or spermine, since they appear to be compet-
itive inhibitors, and their inhibition can be overwhelmed by
increasing the L-arginine concentration (Hu et aL, 1994). Our
data show that, even at high arginine concentrations, a clear
inhibitory effect is observed, although no change in Km was
observed. This suggests that the inhibitory component probably
does not compete with arginine for NO generation. We suppose
that the nature of the inhibitory factor present in HSP is a
small peptide(s) or any other heat-insensitive substance. Caltrin
is an antimicrobial peptide that coats the surface of ejaculated
spermatozoa and may promote the acrosome reaction (Clark
et aL, 1993), an obligatory event in fertilization. It antagonizes
selectively and potently the activating effect of calmodulin on
target enzymes (Comte et al, 1986). Since brain NOS is a
Ca2+/calmodulin-dependent enzyme (reviewed in Nathan and
Xie, 1994), caltrin could be responsible for the inhibition of
brain NOS.
Since we have described a very potent inhibitory effect of
HSP on brain NOS, it is very likely that it plays a physiological
role. It could be an important factor contributing to the
functional state of spermatozoa, preventing cytotoxicity and
infertility associated with microbial infection due to excessive
production of NO. Such an hypothesis can be related to the
results of Rosselli et al. (1995), since these authors found a
positive correlation between the seminal plasma concentration
of nitrite/nitrate and the percentage of immotile spermatozoa.
Moreover, NOS has been shown to be expressed in a variety
of cell types in the non-pregnant human uterus (Telfer et al,
1995). A role for the inhibitory effect of HSP inside the uterus
may apparently be relevant, since it has already been noted
by others that inhibitors of the action of NO might prove
useful in the preservation of spermatozoa (Weinberg et al.,
1995). Whatever the mechanism of its inhibition of NO
formation, HSP could modulate the formation of ROS and
thereby modulate either the toxic lipid peroxidation of sperm
membranes and/or the sperm cell activation process, preventing
its premature capacitation.
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